Cargando…

Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report

BACKGROUND: Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) belongs to Group 1 pulmonary hypertension. Pulmonary veno-occlusive disease (PVOD), which is characterized by venous system aberrations, has been previously reported in CTD-PAH; however, it has rarely b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Xiaofang, Liu, Qiong, Rathinasabapathy, Anandharajan, Zha, Lihuang, Liu, Dongliang, Tang, Yiyang, Sun, Jing, Luo, Hui, Yu, Zaixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847112/ https://www.ncbi.nlm.nih.gov/pubmed/36653758 http://dx.doi.org/10.1186/s12890-023-02322-w

Ejemplares similares

Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China
por: Zeng, Xiaofang, et al.
Publicado: (2021)

Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study
por: Tang, Yiyang, et al.
Publicado: (2021)

Corrigendum: Association of systemic immune-inflammation index with short-term mortality of congestive heart failure: A retrospective cohort study
por: Tang, Yiyang, et al.
Publicado: (2022)

FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Zhang, Wen, et al.
Publicado: (2023)

Rapid disease progress in a PVOD patient carrying a novel EIF(2)AK(4) mutation: a case report
por: Zeng, Xiaofang, et al.
Publicado: (2020)

Serum Anion Gap Is Associated with All-Cause Mortality among Critically Ill Patients with Congestive Heart Failure
por: Tang, Yiyang, et al.
Publicado: (2020)

Development and Validation of Nomogram to Predict Long-Term Prognosis of Critically Ill Patients with Acute Myocardial Infarction
por: Tang, Yiyang, et al.
Publicado: (2021)

Ubiquitin chains: a new way of screening for regulatory differences in pulmonary hypertension
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018)

Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
por: Lin, Wenchao, et al.
Publicado: (2022)

Association between prothrombin time-international normalized ratio and prognosis of post-cardiac arrest patients: A retrospective cohort study
por: Tang, Yiyang, et al.
Publicado: (2023)

Corrigendum: Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension
por: Lin, Wenchao, et al.
Publicado: (2022)

Anti-synthetase syndrome-associated pulmonary veno-occlusive disease
por: Kay, Diana, et al.
Publicado: (2020)

Pulmonary veno‐occlusive disease with vanished pulmonary consolidation
por: Yamasaki, Kei, et al.
Publicado: (2023)

Mitomycin induced pulmonary veno-occlusive disease
por: Kunadu, Afua, et al.
Publicado: (2021)

Genetic cause of pulmonary veno-occlusive disease
por: Mohite, Kaustubh, et al.
Publicado: (2022)

A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure
por: Tang, Yiyang, et al.
Publicado: (2022)

Corrigendum: A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure
por: Tang, Yiyang, et al.
Publicado: (2022)

Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?
por: Luo, Qin, et al.
Publicado: (2019)

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension
por: Beshay, Sarah, et al.
Publicado: (2022)

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
por: West, James, et al.
Publicado: (2021)

Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension
por: Li, Tangzhiming, et al.
Publicado: (2019)

Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension
por: Hajouli, Said, et al.
Publicado: (2019)

Efficacy and safety of oral pulmonary vasodilators in pulmonary veno‐occlusive disease
por: Nakamura, Junichi, et al.
Publicado: (2022)

Reactive Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-Occlusive Disease in a Patient with Repaired Scimitar Syndrome
por: Güttinger, Eva, et al.
Publicado: (2016)

Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera
por: Tachibana, Takayoshi, et al.
Publicado: (2017)

Clinical features of canine pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis
por: Reinero, Carol R., et al.
Publicado: (2018)

Trichloroethylene increases pulmonary endothelial permeability: implication for pulmonary veno-occlusive disease
por: Caliez, Julien, et al.
Publicado: (2020)

Pulmonary hypertension secondary to pulmonary veno occlusive disease: Catastrophe in the catheterization laboratory
por: Sharma, Anuj, et al.
Publicado: (2020)

Haemosiderin-Laden Sputum Macrophages for Diagnosis in Pulmonary Veno-Occlusive Disease
por: Lederer, Heidi, et al.
Publicado: (2014)

Pulmonary veno-occlusive disease: Two children with gradual disease progression()
por: Day, Ronald W., et al.
Publicado: (2016)

Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation
por: Hamada, Takashi, et al.
Publicado: (2023)

Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease
por: Mavrikou, Ioulia, et al.
Publicado: (2023)

Defibrotide for hepatic veno-occlusive disease
Publicado: (2021)

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease
por: Turco, Célia, et al.
Publicado: (2015)

Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog
por: den Toom, Marjolein Lisette, et al.
Publicado: (2018)

Pulmonary veno-occlusive disease in a patient with recently diagnosed systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2019)

Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno‐occlusive disease
por: Nakayama, Hiroki, et al.
Publicado: (2023)

Sudden Death in a Patient with Pulmonary Veno-occlusive Disease (PVOD) and Severe Pulmonary Hypertension
por: Saito, Minako, et al.
Publicado: (2017)

Comprehensive three‐dimensional morphology of neoangiogenesis in pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis
por: Neubert, Lavinia, et al.
Publicado: (2019)

Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling
por: Li, Tangzhiming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s8tuamv16gr5iqmknalglsq995